Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
2
|
| gptkbp:bfsParent |
gptkb:award
|
| gptkbp:acquired |
gptkb:Sanofi
|
| gptkbp:collaborated_with |
gptkb:Sanofi-Synthélabo
gptkb:Hoechst_AG |
| gptkbp:dissolved |
gptkb:2004
|
| gptkbp:employees |
around 100,000 (2003)
|
| gptkbp:founded |
gptkb:1999
|
| gptkbp:headquarters |
gptkb:Paris,_France
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aventis
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:key_people |
gptkb:Henri_de_Castries
|
| gptkbp:products |
vaccines
oncology drugs cardiovascular drugs diabetes medications |
| gptkbp:revenue |
€20 billion (2003)
|
| gptkbp:subsidiary |
gptkb:Aventis_Pharma
gptkb:Genzyme gptkb:Sanofi_Pasteur |
| gptkbp:successor |
gptkb:Sanofi-Aventis
|